Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Drug discovery has long been plagued by high costs, inefficiencies and high failure rates. Therefore, many companies are now adopting AI to accelerate innovation and improve outcomes across every ...

Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 ...

Precise calculations of binding free energy are pivotal in reducing the high costs and inefficiencies of drug discovery. A ...

After offering a deep dive last year into the recipe behind its lead lung fibrosis candidate, Insilico Medicine is now giving ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

Five years since it launched, advances powered by the National Drug Discovery Centre are helping transform medical research in Australia and fast-tracking development of new home-grown treatments.

The Generative AI in Drug Discovery Market was valued at USD 138.5 Million in 2023. It is expected to reach USD 1,435.0 Million by 2033, with a CAGR of 27.1% ...